An outside panel of experts to the U.S. Food and Drug Administration on Tuesday refused to back the effectiveness of oral over-the-counter (OTC) medicines made with phenylephrine, an ingredient widely used in cold and cough syrups.
The panel unanimously voted against the effectiveness of orally administered phenylephrine as a nasal decongestant, adding that no more trials were required to prove otherwise.
The panel vote could lead to the removal of oral phenylephrine, which is a major component of popular products like Benadryl, Advil and Tylenol, from the FDA's list of approved OTC ingredients, barring its sale in the United States."The patient community requires and deserves medications that treat their symptoms safely and effectively and I don't believe that this medication does that," said Jennifer Schwartzott, one of the FDA panelists.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
When Should You Get the New COVID Booster?The Food and Drug Administration (FDA) approved a new round of COVID boosters on Monday.
Read more »
Timeline for supply limits on Novo Nordisk weight-loss drug unclear, US FDA saysThe U.S. Food and Drug Administration said on Tuesday it was not clear when supply of lower doses of Novo Nordisk's Wegovy would normalize, backtracking from its earlier estimates to resume supply of the popular weight-loss drug this month.
Read more »
Key drug in Sudafed, Dayquil and many other decongestants doesn't relieve congestion: FDA'Modern studies, when well conducted, are not showing any improvement in congestion with phenylephrine.'
Read more »
FDA approves updated COVID-19 vaccines amid rising cases and hospitalizationsThe U.S. Food and Drug Administration (FDA) approved updated COVID-19 vaccines from Moderna and Pfizer/BioNTech in response to the surge in cases and hospitalizations.
Read more »
New preeclampsia test predicts who will get dangerous pregnancy complicationA test recently approved by the U.S. Food and Drug Administration,can predict imminent preeclampsia, by looking for biomarkers in the blood.
Read more »
SA germ-zapping robot-maker Xenex clears major FDA hurdleThe U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device.
Read more »